244 related articles for article (PubMed ID: 12061944)
61. Survival and clinical features in Hispanic amyotrophic lateral sclerosis patients.
Martínez HR; Molina-López JF; Cantú-Martínez L; González-Garza MT; Moreno-Cuevas JE; Couret-Alcaraz P; Treviño SA; Webb-Vargas Y; Caro E; Gil-Valadez A; Santos-Guzmán J; Hernandez-Torre M
Amyotroph Lateral Scler; 2011 May; 12(3):199-205. PubMed ID: 21344998
[TBL] [Abstract][Full Text] [Related]
62. Long-term survival in amyotrophic lateral sclerosis: a population-based study.
Pupillo E; Messina P; Logroscino G; Beghi E;
Ann Neurol; 2014 Feb; 75(2):287-97. PubMed ID: 24382602
[TBL] [Abstract][Full Text] [Related]
63. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas.
Nguyen TV; Yueh B
Cancer; 2002 Aug; 95(3):553-62. PubMed ID: 12209747
[TBL] [Abstract][Full Text] [Related]
64. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
Zoccolella S; Simone IL; Lamberti P; Samarelli V; Tortelli R; Serlenga L; Logroscino G
Neurology; 2008 Jan; 70(3):222-5. PubMed ID: 18195267
[TBL] [Abstract][Full Text] [Related]
65. Effect of riluzole (Rilutek) treatment on plasma amino acid percentages in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
Neurol Sci; 2003 Nov; 24(4):290-2. PubMed ID: 14658053
[TBL] [Abstract][Full Text] [Related]
66. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).
Zoing MC; Burke D; Pamphlett R; Kiernan MC
J Clin Neurosci; 2006 Jan; 13(1):78-83. PubMed ID: 16410201
[TBL] [Abstract][Full Text] [Related]
67. The value of database controls in pilot or futility studies in ALS.
Czaplinski A; Haverkamp LJ; Yen AA; Simpson EP; Lai EC; Appel SH
Neurology; 2006 Nov; 67(10):1827-32. PubMed ID: 17130417
[TBL] [Abstract][Full Text] [Related]
68. [Riluzole as a treatment for amyotrophic lateral sclerosis].
Borrás-Blasco J; Plaza-Macías I; Navarro-Ruiz A; Perís-Martí J; Antón-Cano A
Rev Neurol; 1998 Dec; 27(160):1021-7. PubMed ID: 9951030
[TBL] [Abstract][Full Text] [Related]
69. Prediction of survival for patients with bullous pemphigoid: a prospective study.
Joly P; Benichou J; Lok C; Hellot MF; Saiag P; Tancrede-Bohin E; Sassolas B; Labeille B; Doutre MS; Gorin I; Pauwels C; Chosidow O; Caux F; Estève E; Dutronc Y; Sigal M; Prost C; Maillard H; Guillaume JC; Roujeau JC
Arch Dermatol; 2005 Jun; 141(6):691-8. PubMed ID: 15967914
[TBL] [Abstract][Full Text] [Related]
70. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
71. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis.
Cellura E; Spataro R; Taiello AC; La Bella V
Clin Neurol Neurosurg; 2012 Jul; 114(6):550-4. PubMed ID: 22169158
[TBL] [Abstract][Full Text] [Related]
72. [Clinical characteristics of elderly Japanese patients with amyotrophic lateral sclerosis; with special reference to the development of respiratory failure].
Terao S; Miura N; Osano Y; Adachi K; Sobue G
Rinsho Shinkeigaku; 2006 Jun; 46(6):381-9. PubMed ID: 16986698
[TBL] [Abstract][Full Text] [Related]
73. Clinical trials in ALS: an overview.
Turner MR; Parton MJ; Leigh PN
Semin Neurol; 2001 Jun; 21(2):167-75. PubMed ID: 11442325
[TBL] [Abstract][Full Text] [Related]
74. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
Roch-Torreilles I; Camu W; Hillaire-Buys D
Therapie; 2000; 55(2):303-12. PubMed ID: 10967703
[TBL] [Abstract][Full Text] [Related]
75. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis.
Stefan K; Kunesch E; Benecke R; Classen J
Ann Neurol; 2001 Apr; 49(4):536-9. PubMed ID: 11310635
[TBL] [Abstract][Full Text] [Related]
76. What are the implications of early diagnosis? Maintaining optimal health as long as possible.
Brooks BR
Neurology; 1999; 53(8 Suppl 5):S43-5; discussion S55-7. PubMed ID: 10560637
[TBL] [Abstract][Full Text] [Related]
77. [Interest of a computerized ALS database in the diagnosis and follow-up of patients with ALS].
Couratier P; Druet-Cabanac M; Truong CT; Bernet-Bernady P; Dumas M; Vallat JM; Preux PM
Rev Neurol (Paris); 2000 Apr; 156(4):357-63. PubMed ID: 10795012
[TBL] [Abstract][Full Text] [Related]
78. Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study.
Moura MC; Novaes MR; Eduardo EJ; Zago YS; Freitas Rdel N; Casulari LA
PLoS One; 2015; 10(10):e0141500. PubMed ID: 26517122
[TBL] [Abstract][Full Text] [Related]
79. The natural history of ALS is changing: improved survival.
Qureshi M; Schoenfeld DA; Paliwal Y; Shui A; Cudkowicz ME
Amyotroph Lateral Scler; 2009; 10(5-6):324-31. PubMed ID: 19922119
[TBL] [Abstract][Full Text] [Related]
80. Epidemiology of amyotrophic lateral sclerosis and effect of riluzole on disease course.
Cetin H; Rath J; Füzi J; Reichardt B; Fülöp G; Koppi S; Erdler M; Ransmayr G; Weber J; Neumann K; Hagmann M; Löscher WN; Auff E; Zimprich F
Neuroepidemiology; 2015; 44(1):6-15. PubMed ID: 25571962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
